Structural basis of PP2A inhibition by small t antigen

Uhn Soo Cho1, Seamus Morrone, Anna A Sablina

  • 1Department of Biological Structure, University of Washington, Seattle, Washington, United States of America.

Plos Biology
|July 5, 2007
PubMed

Insights

The SV40 small t antigen (ST) oncoprotein disrupts protein phosphatase 2A (PP2A) function. Structural analysis reveals ST binds the PP2A A subunit, explaining its oncogenic activity.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Oncology

Background:

  • The simian virus 40 (SV40) small t antigen (ST) is a known oncoprotein.
  • ST modulates the function of protein phosphatase 2A (PP2A), a key cellular regulator.
  • PP2A activity is regulated by scaffolding (A), catalytic (C), and regulatory (B) subunits.

Purpose of the Study:

  • To elucidate the structural mechanism by which SV40 ST interacts with and perturbs PP2A function.
  • To provide a molecular basis for the oncogenic activity of ST.

Main Methods:

  • Determined the crystal structure of full-length SV40 ST in complex with the PP2A A subunit.
  • Utilized X-ray crystallography at 3.1 Å resolution.

Main Results:

  • The crystal structure reveals ST comprises an N-terminal J domain and a C-terminal unique domain with two zinc-binding motifs.
  • Both the J domain and the second zinc-binding motif of ST bind to the PP2A A subunit, overlapping with the B56 subunit binding site.
  • The first zinc-binding motif of ST is positioned to potentially inhibit the PP2A catalytic C subunit.

Conclusions:

  • The determined structure provides a detailed molecular understanding of ST binding to the PP2A A subunit.
  • These findings offer a structural basis for the oncogenic properties of SV40 ST by explaining its disruption of PP2A.
  • The results highlight potential therapeutic targets for SV40-associated oncogenesis.